Reported Standalone quarterly numbers for Krebs Biochemicals & Industries are:
Net Sales at Rs 9.09 crore in December 2022 down 58.32% from Rs. 21.81 crore in December 2021.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.55 crore in December 2022 up 57.08% from Rs. 12.94 crore in December 2021.
EBITDA stands negative at Rs. 2.97 crore in December 2022 up 69.38% from Rs. 9.70 crore in December 2021.
Krebs Biochem shares closed at 98.80 on February 02, 2023 (NSE) and has given -10.67% returns over the last 6 months and -42.71% over the last 12 months.
Story continues below Advertisement
| Krebs Biochemicals & Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'22 | Sep'22 | Dec'21 | | Net Sales/Income from operations | 9.09 | 20.94 | 21.81 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 9.09 | 20.94 | 21.81 | | EXPENDITURE | | Consumption of Raw Materials | 3.11 | 1.50 | 16.42 | | Purchase of Traded Goods | 0.02 | 4.39 | -- | | Increase/Decrease in Stocks | -1.50 | 7.50 | -0.87 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.91 | 3.76 | 4.20 | | Depreciation | 1.69 | 1.69 | 1.42 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 6.54 | 5.70 | 11.96 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.68 | -3.59 | -11.32 | | Other Income | 0.02 | 0.27 | 0.20 | | P/L Before Int., Excpt. Items & Tax | -4.66 | -3.32 | -11.12 | | Interest | 0.90 | 0.74 | 1.82 | | P/L Before Exceptional Items & Tax | -5.55 | -4.06 | -12.94 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.55 | -4.06 | -12.94 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -5.55 | -4.06 | -12.94 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.55 | -4.06 | -12.94 | | Equity Share Capital | 21.56 | 21.56 | 21.56 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.58 | -1.88 | -6.00 | | Diluted EPS | -2.58 | -1.88 | -6.00 | | EPS After Extra Ordinary | | Basic EPS | -2.58 | -1.88 | -6.00 | | Diluted EPS | -2.58 | -1.88 | -6.00 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
